FI925309A0 - Menetelmä uusien terapeuttisesti käyttökelpoisten 4,5-dihydro-4-okso-5-isopropyyli-imidatso/1,5-a/pyrido/2,3-e/pyratsiinijohdannaisten valmistamiseksi - Google Patents

Menetelmä uusien terapeuttisesti käyttökelpoisten 4,5-dihydro-4-okso-5-isopropyyli-imidatso/1,5-a/pyrido/2,3-e/pyratsiinijohdannaisten valmistamiseksi

Info

Publication number
FI925309A0
FI925309A0 FI925309A FI925309A FI925309A0 FI 925309 A0 FI925309 A0 FI 925309A0 FI 925309 A FI925309 A FI 925309A FI 925309 A FI925309 A FI 925309A FI 925309 A0 FI925309 A0 FI 925309A0
Authority
FI
Finland
Prior art keywords
isopropylimidazo
pyrido
dihydro
oxo
preparation
Prior art date
Application number
FI925309A
Other languages
English (en)
Swedish (sv)
Other versions
FI93836B (fi
FI925309A (fi
FI93836C (fi
Inventor
Holger Claus Hansen
Frank Waetjen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI925309A publication Critical patent/FI925309A/fi
Publication of FI925309A0 publication Critical patent/FI925309A0/fi
Publication of FI93836B publication Critical patent/FI93836B/fi
Application granted granted Critical
Publication of FI93836C publication Critical patent/FI93836C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI925309A 1987-12-08 1992-11-23 Menetelmä uusien terapeuttisesti käyttökelpoisten 4,5-dihydro-4-okso-5-isopropyyli-imidatso/1,5-a/pyrido/2,3-e/pyratsiinijohdannaisten valmistamiseksi FI93836C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK642287A DK160876C (da) 1987-12-08 1987-12-08 Imidazoquinoxalinforbindelser, fremgangsmaade til deres fremstilling, anvendelse af forbindelserne og farmaceutiske praeparater, hvori forbindelserne indgaar
DK642287 1987-12-08
FI885518A FI90548C (fi) 1987-12-08 1988-11-28 Menetelmä uusien terapeuttisesti käyttökelpoisten 4,5-dihydro-4-okso-5-isopropyyli-imidatso/1,5-a/kinoksaliinijohdannaisten valmistamiseksi
FI885518 1988-11-28

Publications (4)

Publication Number Publication Date
FI925309A FI925309A (fi) 1992-11-23
FI925309A0 true FI925309A0 (fi) 1992-11-23
FI93836B FI93836B (fi) 1995-02-28
FI93836C FI93836C (fi) 1995-06-12

Family

ID=8148726

Family Applications (2)

Application Number Title Priority Date Filing Date
FI885518A FI90548C (fi) 1987-12-08 1988-11-28 Menetelmä uusien terapeuttisesti käyttökelpoisten 4,5-dihydro-4-okso-5-isopropyyli-imidatso/1,5-a/kinoksaliinijohdannaisten valmistamiseksi
FI925309A FI93836C (fi) 1987-12-08 1992-11-23 Menetelmä uusien terapeuttisesti käyttökelpoisten 4,5-dihydro-4-okso-5-isopropyyli-imidatso/1,5-a/pyrido/2,3-e/pyratsiinijohdannaisten valmistamiseksi

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI885518A FI90548C (fi) 1987-12-08 1988-11-28 Menetelmä uusien terapeuttisesti käyttökelpoisten 4,5-dihydro-4-okso-5-isopropyyli-imidatso/1,5-a/kinoksaliinijohdannaisten valmistamiseksi

Country Status (18)

Country Link
US (2) US4968682A (fi)
EP (1) EP0320136B1 (fi)
JP (1) JPH01190684A (fi)
KR (1) KR0133079B1 (fi)
AT (1) ATE109147T1 (fi)
AU (1) AU613125B2 (fi)
CA (1) CA1327797C (fi)
DE (1) DE3850861T2 (fi)
DK (1) DK160876C (fi)
ES (1) ES2056941T3 (fi)
FI (2) FI90548C (fi)
IE (1) IE66336B1 (fi)
IL (1) IL88313A (fi)
NO (1) NO169540C (fi)
NZ (1) NZ227212A (fi)
PH (1) PH24818A (fi)
PT (1) PT89170B (fi)
ZA (1) ZA888558B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK155524C (da) * 1987-03-18 1989-09-11 Ferrosan As Kondenserede imidazolderivater og farmaceutiske praeparater indeholdende disse
IL90315A0 (en) * 1988-06-01 1989-12-15 Ferrosan As Imidazoquinoxaline compounds,their preparation and pharmaceutical compositions containing them
DK626288D0 (da) * 1988-11-10 1988-11-10 Ferrosan As Kemisk proces til fremstilling af imidazoquinoxaliner og mellemprodukter til brug i processen
US5602252A (en) * 1989-11-17 1997-02-11 Berlex Laboratories, Inc. Tricyclic pteridinones and a process for their preparation
US5854419A (en) * 1989-11-17 1998-12-29 Schering Aktiengesellschaft Tricyclic pteridinones and a process for their preparation
DK588489D0 (da) * 1989-11-22 1989-11-22 Ferrosan As Heterocykliske forbindelser, deres fremstilling og anvendelse
DK588389D0 (da) * 1989-11-22 1989-11-22 Ferrosan As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5276028A (en) * 1990-06-22 1994-01-04 Nordisk A/S Imidazoquinoxaline compounds
US5371080A (en) * 1990-06-22 1994-12-06 Novo Nordisk A/S Imidazoquinazoline compounds and their use
DK151890D0 (da) * 1990-06-22 1990-06-22 Ferrosan As Heterocykliske forbindelser deres fremstilling og brug
JP3147902B2 (ja) * 1991-06-14 2001-03-19 ファルマシア・アンド・アップジョン・カンパニー イミダゾ〔１，５−ａ〕キノキサリン
JPH0525037A (ja) * 1991-07-01 1993-02-02 Upjohn Co:The 経口投与酵素感受性腸溶製剤
PT625982E (pt) * 1992-02-13 2002-10-31 Upjohn Co 4-oxo- e 4h-imidazo(5,1-c)(1,4)benzoxazinas uteis como agentes de ligacao ao receptor de benzodiazepina
TW274550B (fi) * 1992-09-26 1996-04-21 Hoechst Ag
EP0743855A1 (en) * 1994-01-03 1996-11-27 Acea Pharmaceuticals, Inc. 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/nmda receptor
US5792766A (en) 1996-03-13 1998-08-11 Neurogen Corporation Imidazo 1,5-c! quinazolines; a new class of GABA brain receptor ligands
WO2007087250A2 (en) * 2006-01-23 2007-08-02 Amira Pharmaceuticals, Inc. Tricyclic inhibitors of 5-lipoxygenase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440929A (en) * 1981-07-16 1984-04-03 Usv Pharmaceutical Corporation Imidazoquinoxaline compounds
ZA825094B (en) * 1981-07-16 1983-04-27 Usv Pharma Corp Imidazoquinoxaline compounds
DK476885D0 (da) * 1985-10-17 1985-10-17 Ferrosan As Heterocycliske forbindelser og fremgangsmaader til fremstilling heraf
DK155524C (da) * 1987-03-18 1989-09-11 Ferrosan As Kondenserede imidazolderivater og farmaceutiske praeparater indeholdende disse
DK161148C (da) * 1988-06-14 1991-11-18 Novo Nordisk As Imidazoquinoxalinforbindelser, fremgangsmaade til fremstilling deraf samt farmaceutiske praeprater indeholdende forbindelserne

Also Published As

Publication number Publication date
NO169540B (no) 1992-03-30
IE883347L (en) 1989-06-08
FI93836B (fi) 1995-02-28
ZA888558B (en) 1989-08-30
FI885518A0 (fi) 1988-11-28
NO885442D0 (no) 1988-12-07
NZ227212A (en) 1990-07-26
AU2660288A (en) 1989-06-08
IE66336B1 (en) 1995-12-27
DK160876C (da) 1991-10-14
KR0133079B1 (ko) 1998-04-17
DK642287D0 (da) 1987-12-08
JPH01190684A (ja) 1989-07-31
FI90548B (fi) 1993-11-15
NO169540C (no) 1992-07-08
FI90548C (fi) 1994-02-25
NO885442L (no) 1989-06-09
ES2056941T3 (es) 1994-10-16
PH24818A (en) 1990-10-30
US4968682A (en) 1990-11-06
KR890009931A (ko) 1989-08-04
IL88313A0 (en) 1989-06-30
PT89170B (pt) 1993-06-30
US4999354A (en) 1991-03-12
DK642287A (da) 1989-06-09
FI925309A (fi) 1992-11-23
ATE109147T1 (de) 1994-08-15
AU613125B2 (en) 1991-07-25
EP0320136A3 (en) 1990-12-19
EP0320136A2 (en) 1989-06-14
PT89170A (pt) 1989-12-29
EP0320136B1 (en) 1994-07-27
CA1327797C (en) 1994-03-15
DE3850861D1 (de) 1994-09-01
FI93836C (fi) 1995-06-12
IL88313A (en) 1993-06-10
DE3850861T2 (de) 1994-11-10
FI885518A (fi) 1989-06-09
DK160876B (da) 1991-04-29

Similar Documents

Publication Publication Date Title
FI925309A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 4,5-dihydro-4-okso-5-isopropyyli-imidatso/1,5-a/pyrido/2,3-e/pyratsiinijohdannaisten valmistamiseksi
FI92204C (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten imidatso/1,5-a/kinoksaliinijohdannaisten valmistamiseksi
NO159854C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive beta-karbolin-3-karboksylsyrederivater.
NZ226461A (en) S-oxo-imidazo-(1,5-a)-thienopyrimidine derivatives; pharmaceutical compositions and processes for preparation
FI922267A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 3-isoksatsolyyli-4-okso-imidatso/1,5-a/kinoksaliinijohdannaisten valmistamiseksi
FI922269A (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 4-okso-imidatso/1,5-a/kinoksaliinijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed